Human Investing’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,484
| Closed | -$207K | – | 107 |
|
|
2026
Q1 | $207K | Buy |
+1,484
| New | +$208K | 0.03% | 93 |
|
|
2025
Q4 | – | Sell |
-2,425
| Closed | -$269K | – | 97 |
|
|
2025
Q3 | $269K | Buy |
2,425
+6
| +0.2% | +$682 | 0.04% | 80 |
|
|
2025
Q2 | $268K | Sell |
2,419
-924
| -28% | -$98.3K | 0.04% | 79 |
|
|
2025
Q1 | $375K | Buy |
3,343
+547
| +20% | +$56.4K | 0.07% | 66 |
|
|
2024
Q4 | $258K | Sell |
2,796
-667
| -19% | -$60.1K | 0.05% | 83 |
|
|
2024
Q3 | $290K | Buy |
3,463
+195
| +6% | +$14.9K | 0.05% | 80 |
|
|
2024
Q2 | $224K | Sell |
3,268
-479
| -13% | -$32K | 0.04% | 86 |
|
|
2024
Q1 | $274K | Buy |
3,747
+221
| +6% | +$17K | 0.06% | 78 |
|
|
2023
Q4 | $286K | Sell |
3,526
-1,174
| -25% | -$91.4K | 0.06% | 79 |
|
|
2023
Q3 | $352K | Sell |
4,700
-442
| -9% | -$34K | 0.08% | 75 |
|
|
2023
Q2 | $396K | Sell |
5,142
-1,092
| -18% | -$87.1K | 0.09% | 73 |
|
|
2023
Q1 | $517K | Sell |
6,234
-149
| -2% | -$12.3K | 0.13% | 65 |
|
|
2022
Q4 | $548K | Sell |
6,383
-1,867
| -23% | -$148K | 0.14% | 68 |
|
|
2022
Q3 | $509K | Buy |
8,250
+1,350
| +20% | +$85.1K | 0.13% | 85 |
|
|
2022
Q2 | $426K | Sell |
6,900
-2,573
| -27% | -$159K | 0.1% | 97 |
|
|
2022
Q1 | $563K | Sell |
9,473
-7,122
| -43% | -$455K | 0.12% | 95 |
|
|
2021
Q4 | $1.21M | Sell |
16,595
-265
| -2% | -$18.3K | 0.29% | 52 |
|
|
2021
Q3 | $1.18M | Buy |
16,860
+15
| +0.1% | +$1.05K | 0.28% | 57 |
|
|
2021
Q2 | $1.16M | Sell |
16,845
-133
| -0.8% | -$8.88K | 0.28% | 63 |
|
|
2021
Q1 | $1.1M | Buy |
16,978
+1,704
| +11% | +$110K | 0.28% | 63 |
|
|
2020
Q4 | $890K | Sell |
15,274
-1,349
| -8% | -$81.4K | 0.25% | 86 |
|
|
2020
Q3 | $1.05M | Sell |
16,623
-614
| -4% | -$42.6K | 0.34% | 73 |
|
|
2020
Q2 | $1.33M | Buy |
17,237
+149
| +0.9% | +$11.4K | 0.47% | 53 |
|
|
2020
Q1 | $1.28M | Sell |
17,088
-29,101
| -63% | -$2.01M | 0.55% | 45 |
|
|
2019
Q4 | $3M | Sell |
46,189
-3,357
| -7% | -$219K | 0.98% | 18 |
|
|
2019
Q3 | $3.14M | Sell |
49,546
-149
| -0.3% | -$9.74K | 1.11% | 15 |
|
|
2019
Q2 | $3.36M | Buy |
49,695
+1,225
| +3% | +$80.6K | 1.23% | 13 |
|
|
2019
Q1 | $3.15M | Buy |
48,470
+1,872
| +4% | +$124K | 1.18% | 16 |
|
|
2018
Q4 | $2.92M | Buy |
+46,598
| New | +$3.26M | 1.22% | 15 |
|
Other funds holding GILD
Human Investing's GILD Position: Q2 2026 in Review
Human Investing sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,484 shares — an estimated $207K sold.
Human Investing first reported a position in GILD in Q4 2018 and held it in 29 quarters. The position peaked at $3.36M in Q2 2019. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Human Investing reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Human Investing sold 1,484 Gilead Sciences shares in Q2 2026, an estimated $207K.
- Human Investing first reported a position in Gilead Sciences in Q4 2018 and held it in 29 quarters.
- Human Investing's Gilead Sciences position peaked at $3.36M in Q2 2019.
- 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.